Session » Education - ARHP Poster

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1160

Development of a Shared Decision Making Tool for Osteoporosis Treatment

9:00AM-11:00AM: Abstract Number: 1156

Development of a Taxonomy of Patient Engagement in Health Research

9:00AM-11:00AM: Abstract Number: 1158

Effects of an Educational Program Using Treat to Target Strategy in Korean Patients with Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1153

Exploring Perceptions of a Rheumatoid Arthritis Specific Smoking Cessation Programme

9:00AM-11:00AM: Abstract Number: 1162

How Ehealth Technologies Are Changing the Office Visit: Perspectives from Healthcare Professionals in Rheumatology

9:00AM-11:00AM: Abstract Number: 1164

Impact of E-Learning on Knowledge, Self-Efficacy and Exercise Behaviours of Patients with Axial Spondyloarthritis: Results from a Longitudinal Randomized Control Trial

9:00AM-11:00AM: Abstract Number: 1163

Impact of E-Learning on Perceived Social Role Participation of Patients with Axial Spondyloarthritis: Results from a Longitudinal Randomized Control Trial

9:00AM-11:00AM: Abstract Number: 1154

Promoting Self-Management Techniques for Osteoarthritis Pain: a Pilot Study of Nurse Practitioner Led Coping Skills Training

9:00AM-11:00AM: Abstract Number: 1166

Survey on the Understanding and Practice of T2T for Nurses Engaged in Medical Treatment of Rheumatoid Arthritis

9:00AM-11:00AM: Abstract Number: 1161

Systematic Development of a Patient-Centered Strategy to Improve Tight Control in Daily Clinical Practice

9:00AM-11:00AM: Abstract Number: 1165

The Development of an Interdisciplinary Treatment Program for Fibromyalgia in a Tertiary Medical Center Focused upon Rheumatology and Internal Medicine

9:00AM-11:00AM: Abstract Number: 1155

The Effect of Nurse-Led Follow-up in Rheumatoid Arthritis. a Systematic Review and Meta-Analysis of Randomized Controlled Trails

9:00AM-11:00AM: Abstract Number: 1159

Use of Rheumatology-Specific Patient Navigators for DMARD Adherence: Results from a Pilot Intervention

9:00AM-11:00AM: Abstract Number: 1157

Using Goutpro to Make Medical Trainees Gout Pros

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].